Cara Therapeutic Financials
| CARA Stock | USD 4.99 0.13 2.67% |
Cara |
Understanding current and past Cara Therapeutic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cara Therapeutic's financial statements are interrelated, with each one affecting the others. For example, an increase in Cara Therapeutic's assets may result in an increase in income on the income statement.
Please note, the presentation of Cara Therapeutic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cara Therapeutic's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cara Therapeutic's management manipulating its earnings.
Cara Therapeutic Stock Summary
Cara Therapeutic competes with 22nd Century, and Corbus Pharmaceuticals. Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut. Cara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US1407551092 |
| CUSIP | 140755109 |
| Location | Connecticut; U.S.A |
| Business Address | 400 Atlantic Street, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.caratherapeutics.com |
| Phone | 203 406 3700 |
| Currency | USD - US Dollar |
Cara Therapeutic Key Financial Ratios
Cara Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cara Therapeutic's current stock value. Our valuation model uses many indicators to compare Cara Therapeutic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cara Therapeutic competition to find correlations between indicators driving Cara Therapeutic's intrinsic value. More Info.Cara Therapeutic is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cara Therapeutic's earnings, one of the primary drivers of an investment's value.Cara Therapeutic Systematic Risk
Cara Therapeutic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cara Therapeutic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Cara Therapeutic correlated with the market. If Beta is less than 0 Cara Therapeutic generally moves in the opposite direction as compared to the market. If Cara Therapeutic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cara Therapeutic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cara Therapeutic is generally in the same direction as the market. If Beta > 1 Cara Therapeutic moves generally in the same direction as, but more than the movement of the benchmark.
About Cara Therapeutic Financials
What exactly are Cara Therapeutic Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Cara Therapeutic's income statement, its balance sheet, and the statement of cash flows. Potential Cara Therapeutic investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Cara Therapeutic investors may use each financial statement separately, they are all related. The changes in Cara Therapeutic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cara Therapeutic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Cara Therapeutic Thematic Clasifications
Cara Therapeutic is part of Marijuana investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States
This theme covers Entities with exposure to distribution of Marijuana. Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. Get More Thematic Ideas
| Marijuana | View |
Cara Therapeutic January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cara Therapeutic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cara Therapeutic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cara Therapeutic based on widely used predictive technical indicators. In general, we focus on analyzing Cara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cara Therapeutic's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.5 | |||
| Information Ratio | 0.0812 | |||
| Maximum Drawdown | 71.8 | |||
| Value At Risk | (9.68) | |||
| Potential Upside | 10.7 |
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |